Tamm-Horsfall Protein Binds to Type 1 Fimbriated Escherichia coli and Prevents E. coli from Binding to Uroplakin Ia and Ib Receptors*

The adherence of uropathogenic Escherichia coli to the urothelial surface, a critical first step in the pathogenesis of urinary tract infection (UTI), is controlled by three key elements: E. coli adhesins, host receptors, and host defense mechanisms. Although much has been learned about E. coli adhesins and their urothelial receptors, little is known about the role of host defense in the adherence process. Here we show that Tamm-Horsfall protein (THP) is the principal urinary protein that binds specifically to type 1 fimbriated E. coli, the main cause of UTI. The binding was highly specific and saturable and could be inhibited by d-mannose and abolished by endoglycosidase H treatment of THP, suggesting that the binding is mediated by the high-mannose moieties of THP. It is species-conserved, occurring in both human and mouse THPs. In addition, the binding to THP was much greater with an E. coli strain bearing a phenotypic variant of the type 1 fimbrial FimH adhesin characteristic of those prevalent in UTI isolates compared with the one prevalent in isolates from the large intestine of healthy individuals. Finally, a physiological concentration of THP completely abolished the binding of type 1 fimbriated E. coli to uroplakins Ia and Ib, two putative urothelial receptors for type 1 fimbriae. These results establish, on a functional level, that THP contains conserved high-mannose moieties capable of specific interaction with type 1 fimbriae and strongly suggest that this major urinary glycoprotein is a key urinary anti-adherence factor serving to prevent type 1 fimbriated E. coli from binding to the urothelial receptors.

[1]  T. Sun,et al.  Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. , 1999, Journal of molecular biology.

[2]  S. Hultgren,et al.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.

[3]  D. Dykhuizen,et al.  Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Sobel,et al.  Pathogenesis of urinary tract infection. Role of host defenses. , 1997, Infectious disease clinics of North America.

[5]  E. Sokurenko,et al.  Diversity of the Escherichia coli Type 1 Fimbrial Lectin , 1997, The Journal of Biological Chemistry.

[6]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[7]  T. Sun,et al.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Wallace,et al.  The cellular and molecular basis of gastric mucosal defense , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  T. Sun,et al.  Selective Interactions of UPIa and UPIb, Two Members of the Transmembrane 4 Superfamily, with Distinct Single Transmembrane-domained Proteins in Differentiated Urothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[11]  A. Siitonen,et al.  Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes , 1995, Journal of bacteriology.

[12]  B. Foxman,et al.  Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. , 1995, The Journal of infectious diseases.

[13]  R. O'neill,et al.  A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. , 1994, Carbohydrate research.

[14]  T. Sun,et al.  Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. , 1994, The Journal of biological chemistry.

[15]  T. Sun,et al.  Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins , 1994, The Journal of cell biology.

[16]  E. Sokurenko,et al.  FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes , 1994, Journal of bacteriology.

[17]  T. Sun,et al.  Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane. , 1994, The Journal of biological chemistry.

[18]  T. Sun,et al.  Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. , 1993, Journal of cell science.

[19]  F. Serafini‐Cessi,et al.  Biosynthesis and oligosaccharide processing of human Tamm-Horsfall glycoprotein permanently expressed in HeLa cells. , 1993, Biochemical and biophysical research communications.

[20]  K. Hård,et al.  The Asn-linked carbohydrate chains of human Tamm-Horsfall glycoprotein of one male. Novel sulfated and novel N-acetylgalactosamine-containing N-linked carbohydrate chains. , 1992, European journal of biochemistry.

[21]  E. Sokurenko,et al.  Functional heterogeneity of type 1 fimbriae of Escherichia coli , 1992, Infection and immunity.

[22]  J. Lamont Mucus: The Front Line of Intestinal Mucosal Defense , 1992, Annals of the New York Academy of Sciences.

[23]  A. Schaeffer Potential role of phase variation of type 1 pili in urinary tract infection and bacterial prostatitis , 1991, Infection.

[24]  M. Levison,et al.  Host defense mechanisms in the pathogenesis of urinary tract infection. , 1991, The Medical clinics of North America.

[25]  T. Sun,et al.  Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. , 1990, The Journal of biological chemistry.

[26]  T. Sun,et al.  Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium , 1990, The Journal of cell biology.

[27]  S. Normark,et al.  Host‐specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1‐4Gal‐containing isoreceptors. , 1990, The EMBO journal.

[28]  S. Kumar,et al.  Tamm-Horsfall protein--uromodulin (1950-1990). , 1990, Kidney international.

[29]  T. Yamamoto,et al.  In vitro adherence of type 1-fimbriated uropathogenic Escherichia coli to human ureteral mucosa , 1989, Infection and immunity.

[30]  S. Fihn,et al.  Urinary tract infections: from pathogenesis to treatment. , 1989, The Journal of infectious diseases.

[31]  J. Parkkinen,et al.  Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins , 1988, Infection and immunity.

[32]  B. Eisenstein,et al.  Type 1 fimbriae of Escherichia coli: genetic regulation, morphogenesis, and role in pathogenesis. , 1988, Reviews of infectious diseases.

[33]  F. dall’Olio,et al.  Structural analysis of the preponderant high-mannose oligosaccharide of human Tamm-Horsfall glycoprotein. , 1988, Carbohydrate research.

[34]  B. Davies,et al.  HEPATOTOXICITY OF TETRAHYDROACRIDINE , 1988, The Lancet.

[35]  L. Maurer,et al.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli , 1986, Infection and immunity.

[36]  G. Schoolnik,et al.  Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. , 1985, The Journal of clinical investigation.

[37]  R. D. Marshall,et al.  Structural analysis of the carbohydrate moieties of human Tamm-Horsfall glycoprotein. , 1984, Carbohydrate research.

[38]  F. dall’Olio,et al.  High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein , 1984, Bioscience reports.

[39]  Y. Abe,et al.  Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice , 1983, Infection and immunity.

[40]  S. Clegg Cloning of genes determining the production of mannose-resistant fimbriae in a uropathogenic strain of Escherichia coli belonging to serogroup O6 , 1982, Infection and immunity.

[41]  S. Falkow,et al.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate , 1981, Infection and immunity.

[42]  A. Afonso Isolation and characterisation of glycopeptides from digests of human Tamm-Horsfall glycoprotein. , 1981, Carbohydrate research.

[43]  I. Ørskov,et al.  TAMM-HORSFALL PROTEIN OR UROMUCOID IS THE NORMAL URINARY SLIME THAT TRAPS TYPE 1 FIMBRIATED ESCHERICHIA COLI , 1980, The Lancet.

[44]  R. Hicks THE MAMMALIAN URINARY BLADDERAN ACCOMMODATING ORGAN , 1975 .

[45]  M. Bonneville,et al.  LUMENAL PLASMA MEMBRANE OF THE URINARY BLADDER , 1972, The Journal of cell biology.

[46]  A. Neuberger,et al.  Tamm-Horsfall urinary glycoprotein. The chemical composition. , 1970, The Biochemical journal.

[47]  J. D. Robertson,et al.  A hexagonal arrangement of subunits in membrane of mouse urinary bladder. , 1969, Journal of molecular biology.

[48]  B. Ketterer,et al.  Hexagonal Lattice of Subunits in the Thick Luminal Membrane of the Rat Urinary Bladder , 1969, Nature.

[49]  L. Koss The asymmetric unit membranes of the epithelium of the urinary bladder of the rat. An electron microscopic study of a mechanism of epithelial maturation and function. , 1969, Laboratory investigation; a journal of technical methods and pathology.

[50]  R M Hicks,et al.  THE FINE STRUCTURE OF THE TRANSITIONAL EPITHELIUM OF RAT URETER , 1965, The Journal of cell biology.

[51]  L. S. King An Introduction to the Fine Structure of Cells and Tissues , 1964 .

[52]  J. Roberts Pathophysiology of bacterial cystitis. , 1999, Advances in experimental medicine and biology.

[53]  J. Kamerling,et al.  Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein. , 1999, Glycobiology.

[54]  J. Bates,et al.  Tamm-Horsfall protein inhibits binding of S- and P-fimbriated Escherichia coli to human renal tubular epithelial cells. , 1997, Experimental nephrology.

[55]  H. Mobley,et al.  In vitro adhesion of bacteria to exfoliated uroepithelial cells: criteria for quantitative analysis. , 1995, Methods in enzymology.

[56]  R. M. Smagula,et al.  High-mannose chains of mammalian glycoproteins. , 1993, Methods in molecular biology.

[57]  A. Slomiany,et al.  Role of mucus in gastric mucosal protection. , 1991, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[58]  J. Sobel,et al.  Quantitation of Tamm-Horsfall protein binding to uropathogenic Escherichia coli and lectins. , 1990, The Journal of infectious diseases.

[59]  G. Schoolnik,et al.  Uropathogenic Escherichia coli: molecular mechanisms of adherence. , 1987, Advances in experimental medicine and biology.